Trulieve Cannabis Corp (TCNNF)
6.80
+0.23
(+3.50%)
USD |
OTCM |
Nov 15, 16:00
Trulieve Cannabis Profit Margin (Quarterly): -21.18% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -21.18% |
| June 30, 2024 | -3.96% |
| March 31, 2024 | -7.75% |
| December 31, 2023 | -11.65% |
| September 30, 2023 | -9.23% |
| June 30, 2023 | -143.3% |
| March 31, 2023 | -22.48% |
| December 31, 2022 | -25.81% |
| September 30, 2022 | -38.79% |
| June 30, 2022 | -7.17% |
| March 31, 2022 | -10.06% |
| December 31, 2021 | -23.94% |
| September 30, 2021 | 8.31% |
| Date | Value |
|---|---|
| June 30, 2021 | 19.00% |
| March 31, 2021 | 15.52% |
| December 31, 2020 | 1.80% |
| September 30, 2020 | 12.78% |
| June 30, 2020 | 15.68% |
| March 31, 2020 | 24.57% |
| December 31, 2019 | -99.64% |
| September 30, 2019 | 85.21% |
| June 30, 2019 | 99.32% |
| March 31, 2019 | 33.06% |
| December 31, 2018 | -59.41% |
| September 30, 2018 | 61.79% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-143.3%
Minimum
Jun 2023
24.57%
Maximum
Mar 2020
-16.37%
Average
-8.49%
Median
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 4.73% |
| Karyopharm Therapeutics Inc | -82.70% |
| Apellis Pharmaceuticals Inc | -29.19% |
| cbdMD Inc | 8.89% |
| Flora Growth Corp | -16.77% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.30% |
| Return on Assets | -4.58% |
| Return on Invested Capital | -6.82% |
| Gross Profit Margin (Quarterly) | 60.95% |
| Operating Margin (Quarterly) | -1.29% |
| Return on Net Operating Assets | -5.20% |